TAF to Prevent HBV Reactivation in Cancer Patients

Clinical trial NCT04619082 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04619082
Sponsor: Chiayi Christian Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Reactivation

Start date: 2021-07-01
Primary completion: 2024-12-31
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.